 | • レポートコード：D0804-13660 • 出版社/出版日：GlobalInfoResearch / 2020年8月3日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、109ページ • 納品方法：Eメール • 産業分類：医薬品・治療 |
| Single User | ￥504,600 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥756,900 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,009,200 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、尿酸薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。尿酸薬の種類別市場規模（アロプリノール、フェブキソスタット、プロベネシド）、用途別市場規模（オンライン薬局、小売薬局、病院薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：AstraZeneca plc、Savient Pharmaceuticals、Regeneron Pharmaceuticals、Boehringer Ingelheim GmbH、Novartis AG、Teijin Pharma Ltd、Merck & Co. Inc、GlaxoSmithKline plc、Ironwood Pharmaceuticals ・地域別グローバル市場分析 2015年-2020年 ・尿酸薬の北米市場（アメリカ、カナダ、メキシコ） ・尿酸薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・尿酸薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・尿酸薬の南米市場（ブラジル、アルゼンチン） ・尿酸薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：アロプリノール、フェブキソスタット、プロベネシド ・用途別分析：オンライン薬局、小売薬局、病院薬局 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The Uric Acid Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The most likely (base case) scenario is that the global Uric Acid Drug sales will be xx in 2020 from Uric Acid Drug million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Uric Acid Drug market size is expected to grow at xx% or more annually for the next five years.
This report also researches and evaluates the impact of Covid-19 outbreak on the Uric Acid Drug industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Uric Acid Drug and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
Uric Acid Drug market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Uric Acid Drug market has been segmented into
Allopurinol
Febuxostat
Probenecid
By Application, Uric Acid Drug has been segmented into:
Online Pharmacies
Retail Pharmacies
Hospital Pharmacies
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Uric Acid Drug market presented in the report. This section sheds light on the sales growth of different regional and country-level Uric Acid Drug markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Uric Acid Drug market.
The report offers in-depth assessment of the growth and other aspects of the Uric Acid Drug market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Uric Acid Drug Market Share Analysis
Uric Acid Drug competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Uric Acid Drug sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Uric Acid Drug sales, revenue and market share for each player covered in this report.
The major players covered in Uric Acid Drug are:
AstraZeneca plc
Savient Pharmaceuticals
Regeneron Pharmaceuticals
Boehringer Ingelheim GmbH
Novartis AG
Teijin Pharma Ltd
Merck & Co. Inc
GlaxoSmithKline plc
Ironwood Pharmaceuticals
Among other players domestic and global, Uric Acid Drug market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Uric Acid Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Uric Acid Drug, with price, sales, revenue and global market share of Uric Acid Drug in 2018 and 2019.
Chapter 3, the Uric Acid Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Uric Acid Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Uric Acid Drug market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Uric Acid Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Uric Acid Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Uric Acid Drug Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Allopurinol
1.2.3 Febuxostat
1.2.4 Probenecid
1.3 Market Analysis by Application
1.3.1 Overview: Global Uric Acid Drug Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Online Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Hospital Pharmacies
1.4 Overview of Global Uric Acid Drug Market
1.4.1 Global Uric Acid Drug Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
1.6 COVID-19 Outbreak: Uric Acid Drug Industry Impact
1.6.1 COVID-19 Potential Implications for the Uric Acid Drug
1.6.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Uric Acid Drug
1.6.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.6.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.6.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.6.2 Opportunity Analysis in Covid-19 Crisis
1.6.3 Market Risk and Restraints
1.6.4 Market Driving Force
2 Manufacturers Profiles
2.1 AstraZeneca plc
2.1.1 AstraZeneca plc Details
2.1.2 AstraZeneca plc Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 AstraZeneca plc SWOT Analysis
2.1.4 AstraZeneca plc Product and Services
2.1.5 AstraZeneca plc Uric Acid Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Savient Pharmaceuticals
2.2.1 Savient Pharmaceuticals Details
2.2.2 Savient Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Savient Pharmaceuticals SWOT Analysis
2.2.4 Savient Pharmaceuticals Product and Services
2.2.5 Savient Pharmaceuticals Uric Acid Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Regeneron Pharmaceuticals
2.3.1 Regeneron Pharmaceuticals Details
2.3.2 Regeneron Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Regeneron Pharmaceuticals SWOT Analysis
2.3.4 Regeneron Pharmaceuticals Product and Services
2.3.5 Regeneron Pharmaceuticals Uric Acid Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Boehringer Ingelheim GmbH
2.4.1 Boehringer Ingelheim GmbH Details
2.4.2 Boehringer Ingelheim GmbH Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Boehringer Ingelheim GmbH SWOT Analysis
2.4.4 Boehringer Ingelheim GmbH Product and Services
2.4.5 Boehringer Ingelheim GmbH Uric Acid Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Novartis AG
2.5.1 Novartis AG Details
2.5.2 Novartis AG Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Novartis AG SWOT Analysis
2.5.4 Novartis AG Product and Services
2.5.5 Novartis AG Uric Acid Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Teijin Pharma Ltd
2.6.1 Teijin Pharma Ltd Details
2.6.2 Teijin Pharma Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Teijin Pharma Ltd Product and Services
2.6.4 Teijin Pharma Ltd Uric Acid Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Merck & Co. Inc
2.7.1 Merck & Co. Inc Details
2.7.2 Merck & Co. Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Merck & Co. Inc Product and Services
2.7.4 Merck & Co. Inc Uric Acid Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 GlaxoSmithKline plc
2.8.1 GlaxoSmithKline plc Details
2.8.2 GlaxoSmithKline plc Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 GlaxoSmithKline plc Product and Services
2.8.4 GlaxoSmithKline plc Uric Acid Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Ironwood Pharmaceuticals
2.9.1 Ironwood Pharmaceuticals Details
2.9.2 Ironwood Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Ironwood Pharmaceuticals Product and Services
2.9.4 Ironwood Pharmaceuticals Uric Acid Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Uric Acid Drug Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Uric Acid Drug Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Uric Acid Drug Manufacturer Market Share in 2019
3.3.2 Top 6 Uric Acid Drug Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Uric Acid Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Uric Acid Drug Sales and Market Share by Regions (2015-2020)
4.1.2 Global Uric Acid Drug Revenue and Market Share by Regions (2015-2020)
4.2 North America Uric Acid Drug Sales and Growth Rate (2015-2020)
4.3 Europe Uric Acid Drug Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Uric Acid Drug Sales and Growth Rate (2015-2020)
4.5 South America Uric Acid Drug Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Uric Acid Drug Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Uric Acid Drug Sales, Revenue and Market Share by Country
5.1.1 North America Uric Acid Drug Sales and Market Share by Country (2015-2020)
5.1.2 North America Uric Acid Drug Revenue and Market Share by Country (2015-2020)
5.2 United States Uric Acid Drug Sales and Growth Rate (2015-2020)
5.3 Canada Uric Acid Drug Sales and Growth Rate (2015-2020)
5.4 Mexico Uric Acid Drug Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Uric Acid Drug Sales, Revenue and Market Share by Country
6.1.1 Europe Uric Acid Drug Sales and Market Share by Country (2015-2020)
6.1.2 Europe Uric Acid Drug Revenue and Market Share by Country (2015-2020)
6.2 Germany Uric Acid Drug Sales and Growth Rate (2015-2020)
6.3 UK Uric Acid Drug Sales and Growth Rate (2015-2020)
6.4 France Uric Acid Drug Sales and Growth Rate (2015-2020)
6.5 Russia Uric Acid Drug Sales and Growth Rate (2015-2020)
6.6 Italy Uric Acid Drug Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Uric Acid Drug Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Uric Acid Drug Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Uric Acid Drug Revenue and Market Share by Regions (2015-2020)
7.2 China Uric Acid Drug Sales and Growth Rate (2015-2020)
7.3 Japan Uric Acid Drug Sales and Growth Rate (2015-2020)
7.4 Korea Uric Acid Drug Sales and Growth Rate (2015-2020)
7.5 India Uric Acid Drug Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Uric Acid Drug Sales and Growth Rate (2015-2020)
7.7 Australia Uric Acid Drug Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Uric Acid Drug Sales, Revenue and Market Share by Country
8.1.1 South America Uric Acid Drug Sales and Market Share by Country (2015-2020)
8.1.2 South America Uric Acid Drug Revenue and Market Share by Country (2015-2020)
8.2 Brazil Uric Acid Drug Sales and Growth Rate (2015-2020)
8.3 Argentina Uric Acid Drug Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Uric Acid Drug Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Uric Acid Drug Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Uric Acid Drug Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Uric Acid Drug Sales and Growth Rate (2015-2020)
9.3 Turkey Uric Acid Drug Sales and Growth Rate (2015-2020)
9.4 Egypt Uric Acid Drug Sales and Growth Rate (2015-2020)
9.5 South Africa Uric Acid Drug Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Uric Acid Drug Sales and Market Share by Type (2015-2020)
10.2 Global Uric Acid Drug Revenue and Market Share by Type (2015-2020)
10.3 Global Uric Acid Drug Price by Type (2015-2020)
11 Global Uric Acid Drug Market Segment by Application
11.1 Global Uric Acid Drug Sales Market Share by Application (2015-2020)
11.2 Global Uric Acid Drug Revenue Market Share by Application (2015-2020)
11.3 Global Uric Acid Drug Price by Application (2015-2020)
12 Market Forecast
12.1 Global Uric Acid Drug Sales, Revenue and Growth Rate (2021-2025)
12.2 Uric Acid Drug Market Forecast by Regions (2021-2025)
12.2.1 North America Uric Acid Drug Market Forecast (2021-2025)
12.2.2 Europe Uric Acid Drug Market Forecast (2021-2025)
12.2.3 Asia-Pacific Uric Acid Drug Market Forecast (2021-2025)
12.2.4 South America Uric Acid Drug Market Forecast (2021-2025)
12.2.5 Middle East & Africa Uric Acid Drug Market Forecast (2021-2025)
12.3 Uric Acid Drug Market Forecast by Type (2021-2025)
12.3.1 Global Uric Acid Drug Sales Forecast by Type (2021-2025)
12.3.2 Global Uric Acid Drug Market Share Forecast by Type (2021-2025)
12.4 Uric Acid Drug Market Forecast by Application (2021-2025)
12.4.1 Global Uric Acid Drug Sales Forecast by Application (2021-2025)
12.4.2 Global Uric Acid Drug Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Uric Acid Drug Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Uric Acid Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Uric Acid Drug Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Uric Acid Drug Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. AstraZeneca plc Basic Information, Manufacturing Base and Competitors
Table 9. AstraZeneca plc Uric Acid Drug Major Business
Table 10. AstraZeneca plc Uric Acid Drug Total Revenue (USD Million) (2018-2019)
Table 11. AstraZeneca plc SWOT Analysis
Table 12. AstraZeneca plc Uric Acid Drug Product and Services
Table 13. AstraZeneca plc Uric Acid Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. Savient Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 15. Savient Pharmaceuticals Uric Acid Drug Major Business
Table 16. Savient Pharmaceuticals Uric Acid Drug Total Revenue (USD Million) (2018-2019)
Table 17. Savient Pharmaceuticals SWOT Analysis
Table 18. Savient Pharmaceuticals Uric Acid Drug Product and Services
Table 19. Savient Pharmaceuticals Uric Acid Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Regeneron Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 21. Regeneron Pharmaceuticals Uric Acid Drug Major Business
Table 22. Regeneron Pharmaceuticals Uric Acid Drug Total Revenue (USD Million) (2018-2019)
Table 23. Regeneron Pharmaceuticals SWOT Analysis
Table 24. Regeneron Pharmaceuticals Uric Acid Drug Product and Services
Table 25. Regeneron Pharmaceuticals Uric Acid Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. Boehringer Ingelheim GmbH Basic Information, Manufacturing Base and Competitors
Table 27. Boehringer Ingelheim GmbH Uric Acid Drug Major Business
Table 28. Boehringer Ingelheim GmbH Uric Acid Drug Total Revenue (USD Million) (2018-2019)
Table 29. Boehringer Ingelheim GmbH SWOT Analysis
Table 30. Boehringer Ingelheim GmbH Uric Acid Drug Product and Services
Table 31. Boehringer Ingelheim GmbH Uric Acid Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 33. Novartis AG Uric Acid Drug Major Business
Table 34. Novartis AG Uric Acid Drug Total Revenue (USD Million) (2018-2019)
Table 35. Novartis AG SWOT Analysis
Table 36. Novartis AG Uric Acid Drug Product and Services
Table 37. Novartis AG Uric Acid Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. Teijin Pharma Ltd Basic Information, Manufacturing Base and Competitors
Table 39. Teijin Pharma Ltd Uric Acid Drug Major Business
Table 40. Teijin Pharma Ltd Uric Acid Drug Total Revenue (USD Million) (2018-2019)
Table 41. Teijin Pharma Ltd SWOT Analysis
Table 42. Teijin Pharma Ltd Uric Acid Drug Product and Services
Table 43. Teijin Pharma Ltd Uric Acid Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. Merck & Co. Inc Basic Information, Manufacturing Base and Competitors
Table 45. Merck & Co. Inc Uric Acid Drug Major Business
Table 46. Merck & Co. Inc Uric Acid Drug Total Revenue (USD Million) (2018-2019)
Table 47. Merck & Co. Inc SWOT Analysis
Table 48. Merck & Co. Inc Uric Acid Drug Product and Services
Table 49. Merck & Co. Inc Uric Acid Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 50. GlaxoSmithKline plc Basic Information, Manufacturing Base and Competitors
Table 51. GlaxoSmithKline plc Uric Acid Drug Major Business
Table 52. GlaxoSmithKline plc Uric Acid Drug Total Revenue (USD Million) (2018-2019)
Table 53. GlaxoSmithKline plc SWOT Analysis
Table 54. GlaxoSmithKline plc Uric Acid Drug Product and Services
Table 55. GlaxoSmithKline plc Uric Acid Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 56. Ironwood Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 57. Ironwood Pharmaceuticals Uric Acid Drug Major Business
Table 58. Ironwood Pharmaceuticals Uric Acid Drug Total Revenue (USD Million) (2018-2019)
Table 59. Ironwood Pharmaceuticals SWOT Analysis
Table 60. Ironwood Pharmaceuticals Uric Acid Drug Product and Services
Table 61. Ironwood Pharmaceuticals Uric Acid Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 62. Global Uric Acid Drug Sales by Manufacturer (2018-2019) (K Units)
Table 63. Global Uric Acid Drug Revenue by Manufacturer (2018-2019) (USD Million)
Table 64. Global Uric Acid Drug Sales by Regions (2015-2020) (K Units)
Table 65. Global Uric Acid Drug Sales Market Share by Regions (2015-2020)
Table 66. Global Uric Acid Drug Revenue by Regions (2015-2020) (USD Million)
Table 67. North America Uric Acid Drug Sales by Countries (2015-2020) (K Units)
Table 68. North America Uric Acid Drug Sales Market Share by Countries (2015-2020)
Table 69. North America Uric Acid Drug Revenue by Countries (2015-2020) (USD Million)
Table 70. North America Uric Acid Drug Revenue Market Share by Countries (2015-2020)
Table 71. Europe Uric Acid Drug Sales by Countries (2015-2020) (K Units)
Table 72. Europe Uric Acid Drug Sales Market Share by Countries (2015-2020)
Table 73. Europe Uric Acid Drug Revenue by Countries (2015-2020) (USD Million)
Table 74. Asia-Pacific Uric Acid Drug Sales by Regions (2015-2020) (K Units)
Table 75. Asia-Pacific Uric Acid Drug Sales Market Share by Regions (2015-2020)
Table 76. Asia-Pacific Uric Acid Drug Revenue by Regions (2015-2020) (USD Million)
Table 77. South America Uric Acid Drug Sales by Countries (2015-2020) (K Units)
Table 78. South America Uric Acid Drug Sales Market Share by Countries (2015-2020)
Table 79. South America Uric Acid Drug Revenue by Countries (2015-2020) (USD Million)
Table 80. South America Uric Acid Drug Revenue Market Share by Countries (2015-2020)
Table 81. Middle East & Africa Uric Acid Drug Sales by Countries (2015-2020) (K Units)
Table 82. Middle East & Africa Uric Acid Drug Sales Market Share by Countries (2015-2020)
Table 83. Middle East & Africa Uric Acid Drug Revenue by Countries (2015-2020) (USD Million)
Table 84. Middle East & Africa Uric Acid Drug Revenue Market Share by Countries (2015-2020)
Table 85. Global Uric Acid Drug Sales by Type (2015-2020) (K Units)
Table 86. Global Uric Acid Drug Sales Share by Type (2015-2020)
Table 87. Global Uric Acid Drug Revenue by Type (2015-2020) (USD Million)
Table 88. Global Uric Acid Drug Revenue Share by Type (2015-2020)
Table 89. Global Uric Acid Drug Sales by Application (2015-2020) (K Units)
Table 90. Global Uric Acid Drug Sales Share by Application (2015-2020)
Table 91. Global Uric Acid Drug Sales Forecast by Regions (2021-2025) (K Units)
Table 92. Global Uric Acid Drug Market Share Forecast by Regions (2021-2025)
Table 93. Global Uric Acid Drug Sales Forecast by Type (2021-2025) (K Units)
Table 94. Global Uric Acid Drug Market Share Forecast by Type (2021-2025)
Table 95. Global Uric Acid Drug Sales Forecast by Application (2021-2025)
Table 96. Global Uric Acid Drug Market Share Forecast by Application (2021-2025)
Table 97. Direct Channel Pros & Cons
Table 98. Indirect Channel Pros & Cons
Table 99. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Uric Acid Drug Picture
Figure 2. Global Sales Market Share of Uric Acid Drug by Type in 2019
Figure 3. Allopurinol Picture
Figure 4. Febuxostat Picture
Figure 5. Probenecid Picture
Figure 6. Uric Acid Drug Sales Market Share by Application in 2018
Figure 7. Online Pharmacies Picture
Figure 8. Retail Pharmacies Picture
Figure 9. Hospital Pharmacies Picture
Figure 10. Global Uric Acid Drug Market Status and Outlook (2015-2025) (USD Million)
Figure 11. United States Uric Acid Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Canada Uric Acid Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Mexico Uric Acid Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Germany Uric Acid Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 15. France Uric Acid Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 16. UK Uric Acid Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Russia Uric Acid Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Italy Uric Acid Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 19. China Uric Acid Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Japan Uric Acid Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Korea Uric Acid Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 22. India Uric Acid Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Southeast Asia Uric Acid Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Australia Uric Acid Drug Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 25. Brazil Uric Acid Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Egypt Uric Acid Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Saudi Arabia Uric Acid Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 28. South Africa Uric Acid Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Turkey Uric Acid Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Global Uric Acid Drug Sales Market Share by Manufacturer in 2019
Figure 31. Global Uric Acid Drug Revenue Market Share by Manufacturer in 2019
Figure 32. Top 3 Uric Acid Drug Manufacturer (Revenue) Market Share in 2019
Figure 33. Top 6 Uric Acid Drug Manufacturer (Revenue) Market Share in 2019
Figure 34. Key Manufacturer Market Share Trend
Figure 35. Global Uric Acid Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 36. Global Uric Acid Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 37. Global Uric Acid Drug Revenue Market Share by Regions (2015-2020)
Figure 38. Global Uric Acid Drug Revenue Market Share by Regions in 2018
Figure 39. North America Uric Acid Drug Sales and Growth Rate (2015-2020)
Figure 40. Europe Uric Acid Drug Sales and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Uric Acid Drug Sales and Growth Rate (2015-2020)
Figure 42. South America Uric Acid Drug Sales and Growth Rate (2015-2020)
Figure 43. Middle East & Africa Uric Acid Drug Sales and Growth Rate (2015-2020)
Figure 44. North America Uric Acid Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 45. North America Uric Acid Drug Sales Market Share by Countries (2015-2020)
Figure 46. North America Uric Acid Drug Sales Market Share by Countries in 2018
Figure 47. North America Uric Acid Drug Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 48. North America Uric Acid Drug Revenue Market Share by Countries in 2018
Figure 49. United States Uric Acid Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Canada Uric Acid Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Mexico Uric Acid Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Europe Uric Acid Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 53. Europe Uric Acid Drug Revenue Market Share by Countries (2015-2020)
Figure 54. Europe Uric Acid Drug Revenue Market Share by Countries in 2019
Figure 55. Germany Uric Acid Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 56. UK Uric Acid Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 57. France Uric Acid Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Russia Uric Acid Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Italy Uric Acid Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Asia-Pacific Uric Acid Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 61. Asia-Pacific Uric Acid Drug Sales Market Share by Regions 2019
Figure 62. Asia-Pacific Uric Acid Drug Revenue Market Share by Regions 2019
Figure 63. China Uric Acid Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Japan Uric Acid Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Korea Uric Acid Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 66. India Uric Acid Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 67. Southeast Asia Uric Acid Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 68. South America Uric Acid Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 69. South America Uric Acid Drug Sales Market Share by Countries in 2019
Figure 70. South America Uric Acid Drug Revenue Market Share by Countries in 2019
Figure 71. Brazil Uric Acid Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Argentina Uric Acid Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 73. Middle East and Africa Uric Acid Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. Middle East and Africa Uric Acid Drug Sales Market Share by Countries in 2019
Figure 75. Middle East and Africa Uric Acid Drug Revenue Market Share by Countries (2015-2020)
Figure 76. Middle East and Africa Uric Acid Drug Revenue Market Share by Countries in 2019
Figure 77. Saudi Arabia Uric Acid Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Egypt Uric Acid Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Turkey Uric Acid Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 80. South Africa Uric Acid Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 81. Global Uric Acid Drug Sales and Growth Rate (2021-2025) (K Units)
Figure 82. Global Uric Acid Drug Revenue and Growth Rate (2021-2025) (USD Million)
Figure 83. North America Sales Uric Acid Drug Market Forecast (2021-2025) (K Units)
Figure 84. Europe Sales Uric Acid Drug Market Forecast (2021-2025) (K Units)
Figure 85. Asia-Pacific Sales Uric Acid Drug Market Forecast (2021-2025) (K Units)
Figure 86. South America Sales Uric Acid Drug Market Forecast (2021-2025) (K Units)
Figure 87. Middle East & Africa Sales Uric Acid Drug Market Forecast (2021-2025) (K Units)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel
プレフィルドシリンジ薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Prefilled Syringes Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Prefilled Syringes Dr…- デント病治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The Dent Disease Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization…
- ポリ乳酸・グリコール酸共重合体（PLGA）の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Poly(Lactic-Co-Glycolic Acid) (PLGA) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Poly(Lac…
- 注射用筋肉アミノ酸およびペプチドおよびヌクレオシドの世界市場 2020年：企業別・地域別・種類別・用途別市場予測 Market Overview The Muscular Amino Acid and Peptides and Nucleosides for Injection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global …
- 酸性ガス除去の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Acid Gas Removal market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Acid Gas Removal market repo…